Zimmer Biomet Holdings
$88.29Change from previous close: +0.26%Absolute change: +$0.23
At a glance
- Revenue growth
- +7.20%
- 2025 vs 2024
- Net income growth
- −21.98%
- 2025 vs 2024
- Net margin
- 8.6%
- 2024: 11.8%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 8,232 | 7,679 | 7,394 | 6,940 | — |
| Cost of revenue | 2,494 | 2,191 | 2,084 | 2,020 | — |
| Gross profit | 5,738 | 5,487 | 5,310 | 4,920 | — |
| Selling, general and administrative | 3,257 | 2,930 | 2,839 | 2,762 | — |
| Research and development | 459 | 437 | 459 | 406 | — |
| Operating income | 1,356 | 1,528 | 1,451 | 1,192 | — |
| EBIT | 1,124 | 1,255 | 1,269 | 568 | — |
| EBITDA | 2,217 | 2,251 | 2,220 | 1,495 | — |
| Interest expense | 293 | 218 | 201 | 165 | — |
| Pre-tax income | 831 | 1,037 | 1,067 | 404 | — |
| Income tax | 126 | 131 | 42.2 | 112 | — |
| Net income | 705 | 904 | 1,024 | 231 | — |
| Net income to common shareholders | 705 | 904 | 1,024 | 231 | — |
| Basic EPS | 3.56 | 4.45 | 4.91 | 1.10 | — |
| Diluted EPS | 3.55 | 4.43 | 4.88 | 1.10 | — |
| Average shares (basic) | 198 | 203 | 209 | 210 | — |
| Average shares (diluted) | 199 | 204 | 210 | 210 | — |